Menu
ncarol.com
  • Home
  • Education
  • Financial
  • Business
  • Finance
  • Nyse
  • Health
  • Stocks
  • Banking
ncarol.com

Relecura Makes Patent Innovation Research Platform Free to Coronavirus Researchers in Wake of Pandemic
ncarol.com/10051865

Trending...
  • Inkdnylon Custom Apparel Launches Cost-Saving System for Promotional Products and Custom Apparel in Chicago
  • Heritage at Manalapan Introduces New Single-Family Home Community in One of Monmouth County's Most Desirable Locations
  • U.S. Government Contracts in Excess of 38 Million Secured Through Partner, Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
Relecura Inc
PLEASANTON, Calif. - ncarol.com -- Relecura Inc., a leading provider of AI-powered patent and scientific innovation research,  today announced that Coronavirus researchers across the globe who are working on discovering a solution to the crisis will have free access to its premium research platform until May 31, 2020. Using Relecura's premium research platform, researchers can find and build on existing IP and patent research that will aid them in finding solutions to the current COVID-19 world pandemic.

Interested researchers are invited to take advantage of this unique opportunity by emailing their name, title, work email and company name to researcher@relecura.com.

"The solution to the current crisis we're facing lies in the hands of researchers. Giving them access to the vast amount of existing technical knowledge that is available and the tools to process it to gain greater insight is our way of helping them help us," said George Koomullil, founder of Relecura Inc. "It's also a small way for us to demonstrate our thanks."

Relecura has published two research reports on Coronavirus to assist the research community. The first report, titled Coronavirus Patent Landscape, studies patents related to Coronavirus remedies and provides insights into patent data ranging from antigens and chemotherapeutics to gene therapy and supportive medication. On the other hand, Technical Exploration on Coronavirus explores topics related to Coronaviruses using the technical search engine Tech Explorer.

More on ncarol.com
  • Yield Curve Shifts Drive Retail Traders to AI Trading for 126% Annualized Return Stability
  • Shoutout Joseph Neibich aka Nybyk
  • Meet Joseph Neibich aka Joseph Nybyk of Beachwood Canyon
  • LARUS Launches Business Continuity Framework for IPv4-Dependent Networks
  • A Cure In Sight Advances Ocular Melanoma Advocacy During Rare Disease Week 2026 in Washington, DC

About Relecura:

Relecura Inc is a software product company based in the San Francisco Bay Area. It's subsidiary, Relecura Technologies Pvt. Ltd., is in Bangalore. The company's full-stack cognitive cloud platform aids in managing strategic decisions by drawing powerful insights from patents and scientific literature using artificial intelligence, machine learning and natural language processing. Relecura's enterprise platform integrates the discovery and analysis of public documents with internal company documents, and thus builds a single knowledge base for organization-wide usage. Relecura has an API to help create custom tools for IP and business intelligence. For more details visit www.relecura.com.

Contact
George Koomullil
***@relecura.com


Source: Relecura Inc

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Atelier 4 Appoints Museum Logistics Expert Heather Haldeman as Senior Client Advisor
  • AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
  • Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
  • New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
  • Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
  • Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
  • Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry
  • NEW MANAGEMENT BOOK: Creating a Joy-Centric Culture
  • Alternative Singer Songwriter Big Bus Dream, Proudly Releases, Passionate Decay March 25th
  • QuickTrack by Datalex Transforms Retail Promoter Management with Claude AI and Real-Time Insights
  • Kaltra Introduces Seasonal Discounts on Replacement Coils for Carrier, York, and Trane Chillers
  • Evolve Construction Mobilizes Commercial Storm Response Across Illinois With AI-Powered Damage Documentation and Public Adjusters Partnership
  • Kindred Management Group Announces Opening
  • The World's First Fully Regenerative Economy: Securing Energy, Food, and a Clean Planet
  • Cash Every Denomination Announces Hustlers Haven 2.0 (Legacy Edition) — Exclusively on Even April 24
  • The State of Law Firm Marketing: Top Companies, Awards, and Resources
  • USA Best Book Awards Finalist What Love Leaves Behind Releases March 24
  • Inkdnylon Custom Apparel Launches Cost-Saving System for Promotional Products and Custom Apparel in Chicago
  • ENTOUCH Named Finalist for 2026 North American Inspiring Workplaces Awards
  • Cleveland County Goat Farm NC Kikos Featured in "Feature Farmer Friday" Documentary
_catLbl0 _catLbl1

Popular on ncarol.com

  • Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy - 102
  • Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
  • Training Lofts Launches $1,099 Unlimited Training Membership Featuring Semi-Private Coaching, Nutrition Support, and Recovery Services
  • National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP
  • VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
  • Inkdnylon Custom Apparel Launches Cost-Saving System for Promotional Products and Custom Apparel in Chicago
  • 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
  • Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
  • Caraline Skincare's Gentle Glow Cleansing Oil Named Finalist for Best Face Cleanser at the 2026 CertClean Clean Beauty Awards​
  • Elder Abuse Case Against Healthy Traditions Owner Raises Questions As To The Dire Reality Of Abuse Against The Last Of The Baby Boomers

Similar on ncarol.com

  • Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
  • Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
  • A Cure In Sight Advances Ocular Melanoma Advocacy During Rare Disease Week 2026 in Washington, DC
  • Craigory Dunn Introduces "The Craig Nice Report," A Bold Response to the AI Music Debate
  • Supply & Demand Chain Executive Names Puga Sankara as Recipient of 2026 Pros to Know Award
  • K4Connect launches K4IQ™, an intelligence layer on FusionOS turning data into actionable insights
  • Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
  • New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
  • Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
  • Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute